Brief: Organics Announces Proposed Underwritten Public Offering
19/11/2020 21:24
Oragenics Inc OGEN.A :
* ORGANICS ANNOUNCES PROPOSED UNDERWRITTEN PUBLIC OFFERING
* ORAGENICS - INTENDS TO USE PROCEEDS OF OFFERING TO
CONTINUE
FUNDING PRE-CLINICAL DEVELOPMENT OF SARS-COV-2 VACCINE, TERRA
COV-2, LANTIBIOTICS PROGRAM
Source text for Eikon: ID:nBw5yLpca
Further company coverage: OGEN.A
Recent news on Oragenics
See all newsBrief: Oragenics Reports Continued Clinical Progress, Provides Regulatory And NYSE American Listing Update
Brief: Oragenics Signs Letter Of Intent To License Cardiodialysis™ Technology From Sigyn Therapeutics To Target Tbi-Induced Systemic Inflammation
Brief: Oragenics Inc - Signs Letter Of Intent To License Cardiodialysis From Sigyn Therapeutics - SEC Filing
Brief: Oragenics Activates Second Site In Phase Iia Clinical Trial Of Onp-002 For Concussion And Mild Traumatic Brain Injury.
Brief: Oragenics Enters Settlement Agreement With Ladenburg Thalmann - Sec Filing